Intended for healthcare professionals
Search
Toggle navigation
Current issue
Archive
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
Editorial board
For authors
Advertising
Contact us
News
Web Exclusives
Register
FREE
Sign in
×
Remember me
Not registered?
Forgot your password?
Monk's moments: An uncomfortable truth
Barry E Monk
Dapsone is an unusual drug, with a range of indications from leprosy to vasculitis. Yet, it has an even more unusual history. Dapsone (diaminodiphenylsulfone) was first synthesised in 1908, but it was many years before its therapeutic potential was recognised. During the Second World War, Germany found itself at a significant disadvantage in lacking access to the newly discovered penicillin, which was available to the British and US troops. Much effort was directed into investigating derivatives of the early sulphonamide preparations, which had much weaker antibacterial effect. Josef Vonkennel was a leading dermatologist in Leipzig, an ardent Nazi and adviser on dermatology to the Schutzstaffel (SS). He established a research centre at Buchenwald concentration camp and began experimenting with the effects of dapsone on experimentally induced poison gas burns in inmates. His studies did indeed show that the agent had some therapeutic effects, albeit at the expense of the lives of many of his hapless victims.
Dermatology in practice
2013;
19
(3): 18–18
To continue reading this article, please
sign in
or
register
.
Follow us on
|
|
Latest News
Eli Lilly/Almirall announce long-term results for IL-13 inhibitor Ebglyss in atopic dermatitis
LEO Pharma’s Anzupgo cream granted EC approval in chronic hand eczema
UCB announces two-year data for Bimzelx in hidradenitis suppurativa
Sanofi/Regeneron’s Dupixent shows promise in phase 3 chronic spontaneous urticaria study
Merck announces ten-year data for anti-PD-1 therapy Keytruda in melanoma
This site uses cookies in order to function properly and to allow us to improve our service. By using this site you consent to the use of cookies as set out in our
privacy policy